药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Tolterodine
The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Sunitinib.
Benzonatate
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Sunitinib.
Benzonatate
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Sunitinib.
Benzonatate
Piromidic acid
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Piromidic acid.
Benzonatate
Cibenzoline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Cibenzoline.
Benzonatate
Inotersen
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Inotersen.
Benzonatate
Lorajmine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lorajmine.
Benzonatate
Prajmaline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Prajmaline.
Benzonatate
Cicletanine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Cicletanine.
Benzonatate
Pilsicainide
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Pilsicainide.
Benzonatate
Givinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Givinostat.
Benzonatate
Temefos
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Temefos.
Benzonatate
CUDC-907
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with CUDC-907.
Benzonatate
Bilastine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bilastine.
Benzonatate
Phosmet
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Phosmet.
Benzonatate
Fenthion
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Fenthion.
Benzonatate
Famphur
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Famphur.
Benzonatate
Dichlorvos
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Dichlorvos.
Benzonatate
Coumaphos
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Coumaphos.
Benzonatate
Acrivastine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Acrivastine.